Pharmaceuticals, Biotechnology and Life Sciences
Conference call and webcast scheduled for Thursday, July 29th at 8:00 a.m. ETSAN CARLOS, Calif., July 26, 2021 (GLOBE NEWSWIRE)…
Montrouge, France, July 26, 2021 DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2,…
AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for…
Amendment Extends NDA Acceptance DatePALATINE, Ill., July 26, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an…
-EyeGate signs non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic pharmaceutical company developing a novel, vision restoring…
Item-level analysis from EMERGE trial shows consistency in slowing decline across cognitive, functional and behavioral measures in early Alzheimer’s disease…
Total Prescriptions (TRx) Grew 171% in Second Quarter Prescribers, New Prescriptions and Refill Rates Continue to Grow in Second Quarter…
CAMBRIDGE, Mass., July 26, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
Conference Call on Monday, August 9, 2021, at 8:30 a.m. ETLEXINGTON, Mass., July 26, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ:…
REDWOOD CITY, Calif. and KALAMAZOO, Mich., July 26, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering…